Gabriela Gruia
Director/Board Member at TSCAN THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Network origin in Gabriela Gruia first degree
Entity | Entity type | Industry | |
---|---|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
33
| Subsidiary | Pharmaceuticals: Major | 33 |
Public Company | Biotechnology | 24 | |
Public Company | Biotechnology | 16 | |
Public Company | Pharmaceuticals: Major | 11 | |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore.
10
| Holding Company | Biotechnology | 10 |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gabriela Gruia via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
MORPHOSYS AG | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Boston University | College/University | Doctorate Degree Undergraduate Degree | |
MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Corporate Officer/Principal | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
PHARMING GROUP N.V. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Doctorate Degree | |
Rutgers State University of New Jersey | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Indiana University | College/University | Undergraduate Degree Masters Business Admin | |
The University of Chicago | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Human Resources Officer Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal | |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Masters Business Admin | |
University of Maryland | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
AXCA HEALPAR | Biotechnology | Chairman Chief Executive Officer Comptroller/Controller/Auditor | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
BEIGENE, LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
INSEAD | College/University | Masters Business Admin Graduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
University of California, Davis | College/University | Doctorate Degree Doctorate Degree | |
SHATTUCK LABS, INC. | Biotechnology | Chairman Director/Board Member |
Statistics
International
United States | 38 |
Switzerland | 3 |
France | 3 |
United Kingdom | 2 |
Germany | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 17 |
Commercial Services | 3 |
Finance | 3 |
Health Services | 2 |
Operational
Director/Board Member | 399 |
Corporate Officer/Principal | 218 |
Independent Dir/Board Member | 141 |
Chairman | 81 |
Chief Executive Officer | 77 |
Most connected contacts
Insiders | |
---|---|
Göran Albert Ando | 44 |
George Golumbeski | 36 |
Christoph Westphal | 32 |
David Epstein | 29 |
Timothy Barberich | 26 |
Jean Bizzari | 24 |
Harold Selick | 24 |
Kevin Lalande | 24 |
Bernd Seizinger | 23 |
Ittai Harel | 22 |
Katina Dorton | 22 |
Helen Boudreau | 22 |
Lawrence Olanoff | 22 |
David Hirsch | 20 |
David Southwell | 19 |
- Stock Market
- Insiders
- Gabriela Gruia
- Company connections